CUSIP 09058V103COMBCRXQ4 2025
46 filings · latest Feb 12, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Vanguard Group Inc | 22.27M | $173.73M |
| 2 | Blackrock, Inc. | 21.14M | $164.87M |
| 3 | Ra Capital Management, L.P. | 15.83M | $123.45M |
| 4 | Deerfield Management Company, L.P. | 14.34M | $111.86M |
| 5 | State Street Corp | 11.07M | $86.37M |
| 6 | Kynam Capital Management, LP | 9.37M | $73.06M |
| 7 | Janus Henderson Group PLC | 7.40M | $57.79M |
| 8 | Ubs Group AG | 5.26M | $41.06M |
| 9 |
| 4 | Sep 19, 2025 | Deerfield Mgmt, L.P. | 13G | 5.8% | 12.17M | SEC |
| 5 | May 15, 2025 | Avoro Capital Advisors LLC | 13G/A | 4.2% | 8.70M | SEC |
| 6 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 8.4% | 17.48M | SEC |
| 7 | Nov 7, 2024 | Vanguard Group Inc | 13G/A | 10.0% | 20.73M | SEC |
| 8 | Nov 7, 2024 | Vanguard Group Inc | 13G/A | 9.8% | 20.31M | SEC |
| 9 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 9.8% | 20.31M | SEC |
| 10 | Oct 17, 2024 | State Street Corp | 13G/A | 4.3% | 8.85M | SEC |
See the full Schedule 13D/13G history for Biocryst Pharmaceuticals Inc.
Unlock full history| Geode Capital Management, LLC |
| 5.05M |
| $39.43M |
| 10 | Two Sigma Investments, LP | 4.52M | $35.22M |